Bausch + Lomb Announces Availability for Blink NutriTears Dry Eye Supplement at Optometry’s Meeting

NASHVILLE, Tenn.—Bausch + Lomb Corporation announced on Thursday at Optometry’s Meeting that Blink NutriTears, a clinically proven over-the-counter supplement that targets the key root causes of dry eyes, promotes healthy tear production and provides relief of eye dryness symptoms in as little as two to four weeks, will be available at most major retailers by the end of next month.  Read more...

Neurotech Pharmaceuticals Receives Priority Review of Biologics License Application From the FDA for Treatment of Retinal Disease

CUMBERLAND, R.I.—The U.S. Food and Drug Administration has determined that the Biologic License Application conducted by Neurotech Pharmaceuticals Inc., for NT-501, an investigational encapsulated cell therapy for the treatment of MacTel, is sufficiently complete to permit a substantive review, according to an announcement from Neurotech.  Read more...

Modern Optical Canada Is Recognized for Contributions to Eye See Eye Learn Program

ROSEMERE, Quebec—The Ontario Association of Optometrists in Canada has recognized Modern Optical Canada for its contributions to the Eye See Eye Learn program, which aims to detect, diagnose and treat kindergarten children with vision problems, according to an announcement from Modern Optical in Canada.  Read more...



20/20 Pro to Pro Continuing Education